登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
HCl
化学文摘社编号:
分子量:
36.46
UNSPSC Code:
12352200
PubChem Substance ID:
MDL number:
Concentration:
0.096-0.104 M (alkalimetric), ~0.1 M in H2O
Form:
liquid
Grade:
BioPerformance Certified
grade
BioPerformance Certified
vapor pressure
190 mmHg ( 25 °C)
product line
BioXtra
form
liquid
concentration
0.096-0.104 M (alkalimetric), ~0.1 M in H2O
impurities
insoluble matter, passes filter test
pH
1 (25 °C, 0.1 M in H2O)
bp
100 °C (lit.)
density
1.00 g/mL at 20 °C
anion traces
sulfate (SO42-): ≤10 mg/kg
cation traces
Al: ≤1 mg/kg, As: ≤0.1 mg/kg, Ba: ≤1 mg/kg, Bi: ≤1 mg/kg, Ca: ≤5 mg/kg, Co: ≤1 mg/kg, Cr: ≤1 mg/kg, Cu: ≤1 mg/kg, Fe: ≤1 mg/kg, K: ≤20 mg/kg, Li: ≤1 mg/kg, Mg: ≤1 mg/kg, Mn: ≤1 mg/kg, Mo: ≤1 mg/kg, Na: ≤20 mg/kg, Ni: ≤1 mg/kg, Pb: ≤1 mg/kg, Sr: ≤1 mg/kg, Zn: ≤1 mg/kg
λ
neat
UV absorption
λ: 260 nm Amax: 0.01, λ: 280 nm Amax: 0.01
storage temp.
2-8°C
SMILES string
Cl
InChI
1S/ClH/h1H
InChI key
VEXZGXHMUGYJMC-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under 盐酸 溶液
signalword
Warning
hcodes
pcodes
Hazard Classifications
Met. Corr. 1
存储类别
8B - Non-combustible corrosive hazardous materials
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
易制毒化学品(3类)
此项目有
Douglas M McMillan et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(7), 1804-1812 (2015-01-30)
CYP2D metabolically activates codeine to morphine, which is required for codeine analgesia. Permeability across the blood-brain barrier, and active efflux, suggests that initial morphine in the brain after codeine is due to brain CYP2D metabolism. Human CYP2D is higher in
Marta Kolodziejczak et al.
ACS chemical neuroscience, 6(7), 1219-1230 (2015-04-11)
Maturation of functional neuronal circuits during central nervous system development relies on sophisticated mechanisms. First, axonal and dendritic growth should reach appropriate targets for correct synapse elaboration. Second, pruning and neuronal death are required to eliminate redundant or inappropriate neuronal
Jay G Hosking et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(4), 1005-1015 (2014-10-21)
Successful decision making often requires weighing a given option's costs against its associated benefits, an ability that appears perturbed in virtually every severe mental illness. Animal models of such cost/benefit decision making overwhelmingly implicate mesolimbic dopamine in our willingness to
